electronRx
electronRx is a Cambridge-based health tech company dedicated to transforming respiratory health through digital biomarkers and continuous patient insights. Their mission is to partner with pharma to create data-enriched therapeutics, leveraging innovative technology to improve lives and advance healthcare outcomes. They focus on developing non-invasive, smartphone-based monitoring solutions and digital health platforms to support early diagnosis, management, and prevention of respiratory and cardiovascular diseases.
Industries
Nr. of Employees
small (1-50)
electronRx
Eagle Labs, 28 Chesterton Rd, Cambridge CB4 3AZ
Products
Mobile software platform for continuous respiratory and cardiac monitoring
A mobile application that passively collects respiratory and cardiac signals using existing smartphone hardware, derives longitudinal pulmonary function and cardiac metrics, and provides analytics for clinicians and research studies.
Regulated pulmonary function SaMD for clinical and research use
Regulated software intended to provide pulmonary function measurements, validated against spirometry, and designed to integrate with clinical workflows for monitoring respiratory disease and supporting therapeutic decision-making.
Mobile software platform for continuous respiratory and cardiac monitoring
A mobile application that passively collects respiratory and cardiac signals using existing smartphone hardware, derives longitudinal pulmonary function and cardiac metrics, and provides analytics for clinicians and research studies.
Regulated pulmonary function SaMD for clinical and research use
Regulated software intended to provide pulmonary function measurements, validated against spirometry, and designed to integrate with clinical workflows for monitoring respiratory disease and supporting therapeutic decision-making.
Services
Design and execution of clinical studies and statistical validation comparing mobile-derived physiological measures with gold-standard spirometry and producing clinical-grade evidence for regulators and payers.
Provision of continuous remote endpoints, patient selection support, and longitudinal monitoring to reduce trial duration and sample size while enabling decentralized trial participation.
Simulation and predictive forecasting of emergency department and hospital patient flow to identify bottlenecks and evaluate operational interventions.
Commercial and technical partnership models to integrate continuous monitoring capabilities with therapeutic offerings, including ecosystem planning, workflow integration and payer engagement support.
Design and execution of clinical studies and statistical validation comparing mobile-derived physiological measures with gold-standard spirometry and producing clinical-grade evidence for regulators and payers.
Provision of continuous remote endpoints, patient selection support, and longitudinal monitoring to reduce trial duration and sample size while enabling decentralized trial participation.
Simulation and predictive forecasting of emergency department and hospital patient flow to identify bottlenecks and evaluate operational interventions.
Commercial and technical partnership models to integrate continuous monitoring capabilities with therapeutic offerings, including ecosystem planning, workflow integration and payer engagement support.
Expertise Areas
- Digital biomarkers
- Remote patient monitoring
- Respiratory monitoring and pulmonary function assessment
- Machine learning for clinical prediction
Key Technologies
- Smartphone-based physiological sensing
- Optical imaging for lung volumetrics
- Continuous spirometry-like measurement
- Heart rate and heart rate variability monitoring
News & Updates
electronRx showcased its respiratory health solutions at CES 2025, emphasizing the importance of meaningful innovation over data overload.
A detailed reflection on the company's experience at CES 2025, highlighting the global stage for health tech innovation.
Analysis of how continuous respiratory monitoring can transform pharma economics and market potential.
An insightful review of CES 2025, focusing on health tech innovation, data challenges, and the future of respiratory health solutions.
Information on how electronRx seeks partnerships to support respiratory health advancements.
Exploration of how digital biomarkers can improve patient monitoring and clinical decision-making.
electronRx showcased its respiratory health solutions at CES 2025, emphasizing the importance of meaningful innovation over data overload.
A detailed reflection on the company's experience at CES 2025, highlighting the global stage for health tech innovation.
Analysis of how continuous respiratory monitoring can transform pharma economics and market potential.
An insightful review of CES 2025, focusing on health tech innovation, data challenges, and the future of respiratory health solutions.
Information on how electronRx seeks partnerships to support respiratory health advancements.
Exploration of how digital biomarkers can improve patient monitoring and clinical decision-making.